Zander AR - Search Results

1

CD34 splice variant: an attractive marker for selection of gene-modified cells.

Fehse B, Richters A, Putimtseva-Scharf K, Klump H, Li Z, Ostertag W, Zander AR, Baum C. Fehse B, et al. Among authors: zander ar. Mol Ther. 2000 May;1(5 Pt 1):448-56. doi: 10.1006/mthe.2000.0068. Mol Ther. 2000. PMID: 10933966 Free article.

2

Bicistronic retroviral vectors for combining myeloprotection with cell-surface marking.

Hildinger M, Schilz A, Eckert HG, Bohn W, Fehse B, Zander A, Ostertag W, Baum C. Hildinger M, et al. Gene Ther. 1999 Jul;6(7):1222-30. doi: 10.1038/sj.gt.3300942. Gene Ther. 1999. PMID: 10455430

3

Establishment of an optimised gene transfer protocol for human primary T lymphocytes according to clinical requirements.

Ayuk F, Li Z, Kühlcke K, Lindemann C, Schade U, Eckert HG, Zander A, Fehse B. Ayuk F, et al. Gene Ther. 1999 Oct;6(10):1788-92. doi: 10.1038/sj.gt.3300999. Gene Ther. 1999. PMID: 10516731

4

Selective immunoaffinity-based enrichment of CD34+ cells transduced with retroviral vectors containing an intracytoplasmatically truncated version of the human low-affinity nerve growth factor receptor (deltaLNGFR) gene.

Fehse B, Uhde A, Fehse N, Eckert HG, Clausen J, Rüger R, Koch S, Ostertag W, Zander AR, Stockschläder M. Fehse B, et al. Among authors: zander ar. Hum Gene Ther. 1997 Oct 10;8(15):1815-24. doi: 10.1089/hum.1997.8.15-1815. Hum Gene Ther. 1997. PMID: 9358031

5

T lymphocytes as targets of gene transfer with Moloney-type retroviral vectors.

Ayuk FA, Zander AR, Fehse B. Ayuk FA, et al. Among authors: zander ar. Curr Gene Ther. 2001 Nov;1(4):325-37. doi: 10.2174/1566523013348274. Curr Gene Ther. 2001. PMID: 12109060 Review.

6

A novel 'sort-suicide' fusion gene vector for T cell manipulation.

Fehse B, Kustikova OS, Li Z, Wahlers A, Bohn W, Beyer WR, Chalmers D, Tiberghien P, Kühlcke K, Zander AR, Baum C. Fehse B, et al. Among authors: zander ar. Gene Ther. 2002 Dec;9(23):1633-8. doi: 10.1038/sj.gt.3301828. Gene Ther. 2002. PMID: 12424616

7

High-dose multidrug resistance in primary human hematopoietic progenitor cells transduced with optimized retroviral vectors.

Eckert HG, Stockschläder M, Just U, Hegewisch-Becker S, Grez M, Uhde A, Zander A, Ostertag W, Baum C. Eckert HG, et al. Blood. 1996 Nov 1;88(9):3407-15. Blood. 1996. PMID: 8896405 Free article.

8

Purging and haemopoietic progenitor cell selection by CD34+ cell separation.

Krüger W, Gruber M, Hennings S, Fehse N, Fehse B, Gutensohn K, Kröger N, Zander AR. Krüger W, et al. Among authors: zander ar. Bone Marrow Transplant. 1998 Apr;21(7):665-71. doi: 10.1038/sj.bmt.1701156. Bone Marrow Transplant. 1998. PMID: 9578305

9

Impact of a new generation of gene transfer markers on gene therapy.

Fehse B, Li Z, Schade UM, Uhde A, Zander AR. Fehse B, et al. Among authors: zander ar. Gene Ther. 1998 Apr;5(4):429-30. doi: 10.1038/sj.gt.3300666. Gene Ther. 1998. PMID: 9614565 No abstract available.

10

Highly-efficient gene transfer with retroviral vectors into human T lymphocytes on fibronectin.

Fehse B, Schade UM, Li Z, Uhde A, Koch S, Goller B, Rüger R, Fehse N, Stockschläder M, Zander AR. Fehse B, et al. Among authors: zander ar. Br J Haematol. 1998 Jul;102(2):566-74. doi: 10.1046/j.1365-2141.1998.00785.x. Br J Haematol. 1998. PMID: 9695974 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

444 results

Search Page

Filters